Skip to content
10-Q

Quarterly Report

LENZ THERAPEUTICS, INC. LENZ

0001815776-25-000032

← back to feed
Filed
May 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 1, 2025 28.15M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $23.04M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $20.16M
Current Liabilities Q1 2025 · Mar 31, 2025 $8.57M
Current Liabilities Q1 2025 · Dec 31, 2024 $10.41M
Total Liabilities Q1 2025 · Mar 31, 2025 $9.24M
Total Liabilities Q1 2025 · Dec 31, 2024 $11.22M
Current Assets Q1 2025 · Mar 31, 2025 $197.86M
Current Assets Q1 2025 · Dec 31, 2024 $211.92M
Total Assets Q1 2025 · Mar 31, 2025 $201.25M
Total Assets Q1 2025 · Dec 31, 2024 $215.3M
Shares Diluted Q1 2025 · Mar 31, 2024 4.72M sh
Capex Q1 2025 · Mar 31, 2024 $0
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$23.94M
Stockholders Equity Q1 2025 · Mar 31, 2024 $198.17M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$92.71M
Eps Diluted Q1 2025 · Mar 31, 2024 −$3.53
Eps Basic Q1 2025 · Mar 31, 2024 −$3.53
Sga Expense Q1 2025 · Mar 31, 2024 $5.55M
Rd Expense Q1 2025 · Mar 31, 2024 $10.54M
Net Income Q1 2025 · Mar 31, 2024 −$16.65M
Operating Income Q1 2025 · Mar 31, 2024 −$16.09M